logo

Myriad Genetics Inc. (MYGN)



Trade MYGN now with
  Date
  Headline
3/2/2021 7:19:41 AM Myriad Genetics Announces Precision Oncology Collaboration With Intermountain Precision Genomics
2/23/2021 4:09:13 PM Myriad Genetics Q4 GAAP Loss/Shr $0.59 And Adjusted Loss/Shr $0.12
1/19/2021 7:15:41 AM Myriad Genetics Gets Reimbursement For BRACAnalysis Diagnostic System In Japan
1/8/2021 7:09:21 AM Myriad Genetics Receives First Reimbursement Decision For Myriad MyChoice Diagnostic System
9/10/2020 7:33:24 AM Myriad Genetics Adds Rashmi Kumar To Board
8/13/2020 4:23:11 PM Myriad Genetics Q4 Loss/share $0.74 Vs. Loss $0.06 Year Ago
7/22/2020 7:22:53 AM Myriad Genetics Adds Daniel Skovronsky To Board; Walter Gilbert To Retire From Board
7/7/2020 7:24:15 AM Myriad Announces New Studies Validating Ability Of RiskScore Test
7/6/2020 7:10:16 AM Myriad Announces New Collaboration With OptraHEALTH To Implement Cognitive ChatBOT Named Gene
7/1/2020 7:12:53 AM Myriad Genetics Launches New Patient Home Collection Kit For GeneSight® Psychotropic Test
6/15/2020 7:12:27 AM Myriad Genetics Receives Favorable Coverage Decisions For Prolaris
6/4/2020 7:08:25 AM Myriad Genetics Reports Publication Of Prospective Clinical Study Of EndoPredict Test
5/28/2020 7:19:33 AM Myriad Genetics Names Daniel Spiegelman To Its Board